1. Home
  2. Health
  3. Headaches & Migraines
Migraineurs Keep Working Despite Pain
Workplace Survey Shows Sufferers “Tough Out” Migraines Rather Than Seek Effective Treatment

       
 On Our Forum
"I am a medical transcriptionist at a large hospital and work from home. I have recently been (formally) verbally disciplined at work with regard to my absences because I do not qualify for FMLA due to my part-time status and vacation days, sick days, etc. The next step in the process will be written documentation if I incur any absence at all ..."
Join the discussion

   
  Related Resources
• Is Your Insurance Company Limiting Your Triptans?
• Triptans: Overview and Profiles

   
 Elsewhere on the Web
• MAGNUM: Drug Utilization Reviews
• MAGNUM: Limits Burden Patients
• NHF: National Headache Foundation

   

  Free Newsletter

Email Address

Subscribe to:
BEATING
HEADACHES

Email Newsletter
 

Results of a recent survey on Migraine in the workplace serve to reinforce workplace problems of which Migraineurs were already aware and to point out other significant problems. The survey, conducted by HarrisInteractive and sponsored by Pfizer Inc., is the first to examine the impact of Migraine in the workplace and the efforts of Migraine sufferers to maintain their productivity.

Impact:
Of the more than 3,000 American Migraineurs surveyed, 66% "toughed it out" while continuing to work despite the debilitating symptoms of their Migraine attacks. Nine out of 10 Migraine sufferers polled said they have suffered a Migraine at work.

Of those who had a Migraine at work, 91 percent said their ability to function on the job was affected “somewhat” or a “great deal.” This translates to about 400 hours per person of diminished performance a year, based on national projections from the survey sample.

In addition, respondents said they lost the equivalent of more than four days of work a year on average because of Migraine. Based on an estimated 18.5 million Migraine sufferers in the workforce, Migraine results in roughly 80 million lost workdays per year. Those reporting severe Migraine – about 20% of all sufferers – lost twice as much time in the past three months alone.

What's the Problem?
Simply put:

  1. Too many Migraineurs do not seek medical care for their Migraines.

  2. Too many times, medications that are not specifically for Migraine are prescribed, and don't effectively treat Migraine.

  3. All too often Migraineurs aren't well enough educated about the disease to know to ask their doctors about Migraine-specific treatments or lack the confidence to question their doctors.

“These men and women tough it out to get the job done in order to advance in their careers or because they don’t want to let down their coworkers,” said Jan Lewis Brandes, M.D., Clinical Faculty in Neurology, Vanderbilt University School of Medicine in Nashville, TN. “But the tragedy is that most of them don’t have to put on a brave face – there is help in the form of proper diagnosis and effective treatment.”

Still, 61% of Migraine sufferers polled said they rely on over-the-counter (OTC) medications or take nothing at all. Of those who take prescription medications, only one third said they are “satisfied or very satisfied” with their treatment.

“Many Migraine patients are put on therapies that are not specific for Migraine. And because many sufferers aren’t aware that there are effective medications available specifically for Migraine, they don’t talk to their doctors about their condition or ask for better therapies,” Dr. Brandes said.

While they are toughing it out, most Migraine sufferers reveal that Migraine does impact job performance. Eighty-two percent of those polled said Migraines hindered their ability to solve problems as well as affected their ability to interact with others.

Women reported they feel less in control than men over the impact of Migraine on their family and social lives, while men reported slightly less control than women on their careers. Nonetheless, women were more likely to seek support from colleagues. Only 17% of women polled said their colleagues didn’t know about their Migraine condition, vs. 29% of men. Men in the survey acknowledged that they were less comfortable discussing Migraines and were less likely to have told their boss about their headache condition, or to have admitted that Migraine was the reason they reported in sick.

Too Many Misconceptions and Not Enough Understanding Exist:
A majority of men and women who were polled said that it is difficult for non-sufferers to understand how Migraines affected their quality of life (89%).

“People’s lives and careers, as well as their sense of personal well-being, are far too valuable to lose to Migraine,” Dr. Brandes said. “Migraine sufferers don’t have to tough it out because there are effective treatments available. To be empowered to take charge of both their disease and their lives, Migraine sufferers need to feel that others do understand and empathize with them, and that Migraine is not to be minimized or trivialized. This landmark survey shows us just how significant the impact of Migraine is,” she said.

Poll Results Graphs:
(Click on any of the images to see a larger version.)


Images © 2003, Pfizer, Inc.
Used with the permission of Pfizer.



Poll Methodology:
Three-thousand sixty-four U.S. adults who experience migraine – 1,425 men and 1,639 women – were surveyed online from October 28 through November 5, 2002. Respondents for this report include 2,206 migraine sufferers – 1,089 men and 1,117 women – who are currently employed or self-employed full- or part-time (70% of all adult migraine sufferers on a weighted basis).

Respondents were screened from Harris Interactive’s online panel and include adults who have been diagnosed with migraine as well as adults who, while not diagnosed, believe that they experience migraine. The self-administered online questionnaire took an average of 18 minutes to complete.

About Pfizer:
Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines, for humans and animals, and many of the world's best-known consumer products.

Pfizer Neuroscience is committed to pioneering innovative therapies for neurological and psychiatric disorders. Pfizer’s experience in the areas of depression, anxiety, schizophrenia, Alzheimer’s disease and epilepsy has helped bring leading medicines to market for the treatment of these disorders.

Neurologic and psychiatric disorders represent an important priority in Pfizer’s $5.2 billion development effort, with more than 20 percent of the research and development budget allocated to the development of more effective neuroscience medicines for disorders such as mood and anxiety disorders, Migraine, neuropathic pain, fibromyalgia, epilepsy and smoking cessation.

For more information about Migraine or the Harris Poll, please visit www.MigraineRelief.com.
 
~ Teri Robert

for a printer-friendly version of this feature, click HERE
to recommend this page to a friend, click HERE


Previous Articles

Subscribe to the Newsletter
Name
Email

Chat Status:


Explore Headaches & Migraines
About.com Special Features

8 Ways to Cut Drug Costs

Learn how to save money on medications with these recommendations. More >

Healthy Bodies, Healthy Minds

Keep yourself, and your family, happy and healthy this fall with these tips. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. Headaches & Migraines

©2009 About.com, a part of The New York Times Company.

All rights reserved.